Nicolas Gendron on TITAN’s Recent Study: Insights on Managing Pregnancy in Antithrombin Deficiency
Nicolas Gendron, Research Fellow, Hematologist at Boston Children’s Hospital, shared a proud post on LinkedIn:
‘‘Pregnancy and Antithrombine Deficiency
We are very pleased to announce the online publication of our French recommendations on the management of pregnancy in women with congenital antithrombin deficiency (ATD), published in Thromb Haemost (Thrombosis Haemostasis Journal).
Congenital antithrombin deficiency is a rare condition but is associated with a major thromboembolic risk, particularly in the context of pregnancy.
Given the limited literature and heterogeneous international recommendations, the Thrombosis, Anticoagulants, and Antiplatelet Agents (TITAN) group of the French Society for Thrombosis and Hemostasis (SFTH) conducted an in-depth review of the literature in order to propose concrete elements to aid decision-making.
These proposals address:
- The indication and dosage regimen for anticoagulants
- Relevant biological monitoring
- The role of antithrombin concentrates during and at the end of pregnancy
- The crucial importance of multidisciplinary coordination between hematologists, obstetricians, and anesthesiologists.
Read the full article here.
Congratulations to all the co-authors for this collective work! Special thanks to Laurent for leading the project.
Mauge Laetitia, Hugo Madar, Julie Carré, Mathieu Fiore, Christine Mouton, Valérie Proulle, Suchon Pierre, Nathalie Trillot, Thomas Lechat, Loïc Sentilhes and Laurent Macchi.”
Article: How to Manage Venous Thromboembolism Risk during Pregnancy in Patients with Inherited Antithrombin Deficiency?
Authors: Laetitia Mauge , Hugo Madar, Julie Carré, Mathieu Fiore, Nicolas Gendron, Christine Mouton, Valérie Proulle, Pierre Suchon, Nathalie Trillot, Thomas Lechat, Loïc Sentilhes, Laurent Macchi, On behalf of the TITAN group of the French Society of Thrombosis and Haemostasis (SFTH)

Stay updated on the latest scientific advancements in the field of hemostasis and thrombosis with Hemostasis Today.
-
Sep 16, 2026, 16:06Katrina Louise Manalaysay: In Your 20s, You Might be Given the Opportunity to Donate Blood for the First Time
-
Sep 16, 2026, 15:45Matthew Hazell: A Brilliant Explanation of Phenotype vs Genotype Using a LEGO House
-
Sep 16, 2026, 15:23Ahmad Al-Ramahi: Presenting the Military Pharmacists Blood Training Course at the FIP World Congress
-
Sep 16, 2026, 15:21HIT Reimagined: Can 12-Lipoxygenase Inhibition Stop Immune Thrombosis?
-
Sep 16, 2026, 14:42Ruchi Punamia: Beyond the Blood Bank and The Clinical Impact of Apheresis
-
Sep 16, 2026, 14:06Kalyan Roy: Celebrating Apheresis, Advancing Care, Saving Lives
-
Sep 16, 2026, 13:38Andrew Zapfel: Advancing Sickle Cell Disease Care and Research
-
Sep 16, 2026, 13:30Thirunavukkarasu Angappan: Why Plasma-Derived Factor VIII Still Matters for Inhibitor Patients
-
Sep 16, 2026, 13:22Matthew Hazell: New BSH Guidance for Fetal, Neonatal and Paediatric Transfusion